May 5, 2015
Outside of studying at the library, you might find Shaina Hasan moving gracefully as she performs classical Indian dance. You might see Carl Buchholz zip past you as he cycles through town and up Mt. Lemmon. But on May 14th, we found them both at the UA College of Science graduation, recognized respectively as the Spring 2015 College of Science Outstanding Senior and Excellence in Undergraduate Research Awardee.
Hasan, who was awarded the MCB Outstanding Senior Award, and Buchholz, who was awarded both the MCB Excellence in Undergraduate Research Award and the Outstanding Senior Awar...Read More
January 23, 2015
ALS (Lou Gehrig's Disease) is a progressive neurodegenerative disease that affects nerve cells in the brain and the spinal cord. Daniela Zarnescu, associate professor at Molecular and Cellular Biology, and Alyssa Coyne, a graduate student in the UA's Neuroscience Graduate Interdisciplinary Program, together with their colleagues, have identified a a clear molecular defect at the junctions between neurons and muscles, which may provide greater insight into the fundamental mechanisms of ALS. Their finding was published in the Journal of Neuroscience.
December 9, 2014
Prion aggregates are associated with diseases including Alzheimer's, Huntington's and Parkinson's. It's believed that when prion aggregates arise, cells cannot get rid of them. A recent work from the lab of Tricia Serio, professor and head of the MCB department, showed however that yeast cells can clear themselves of prion aggregates at an increased temperature. This work suggests that inducing stress responses may one day help develop treatments for diseases associated with misfolded prion proteins. The work is published today at eLife -- see the paper here, and the UA news report here.Read More
December 5, 2014
The 2014 Arizona Daily Star Science Supplement features MCB Professors Ross Buchan (page 12), Ted Weinert (page 12), Gail Burd and Debra Tomanek (page 26). Read the story here please.Read More
September 25, 2014
Dr. Joyce Schroeder, a professor of molecular and cellular biology at the University of Arizona and researcher at the Arizona Cancer Center, discusses her work developing a new drug to treat breast cancer. The cutting edge work is funded by the Arizona Biomedical Research Commission. Dr. Schroeder is also the Chief Science Officer at Arizona Cancer Therapeutics. See more on Dr. Shroeder's work on her labpage.Read More